Drug Interaction Report

Sulodexide and Sertraline: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Sulodexide

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 42 documented Sulodexide interactions, 38 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Combining sertraline and sulodexide can add up to a higher bleeding risk, so watch for bruising or bleeding and keep your care team in the loop. Don't stop either drug on your own; let them monitor you and adjust as needed.

Taking sertraline with sulodexide can raise your chance of bleeding or bruising. Sertraline is an antidepressant, and one of its lesser-known effects is that it makes your platelets (the cells that help your blood clot) a little less sticky. Sulodexide is a blood-thinner-type medicine. Put together, they can add up and make it easier to bleed.

You might notice things like nosebleeds, bruising more easily, or small red spots on the skin. Serious bleeding is possible but less common. Please don't stop either medicine on your own. Let your pharmacist or doctor know you take both so they can keep an eye on you and adjust things if needed.

Effect: Additive bleeding risk when sertraline is combined with sulodexide (an antithrombotic/heparinoid agent).

  • Mechanism: SSRIs deplete platelet serotonin, impairing serotonin-mediated platelet aggregation; this is additive to sulodexide's anticoagulant/antithrombotic activity (PD interaction, not CYP-mediated).
  • Direction: Increased bleeding risk; neither agent is a prodrug requiring activation here.
  • Onset: Delayed. Evidence: Probable (case-control/cohort data with SSRI + anticoagulant).
  • Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, and signs of major hemorrhage. Counsel the patient on bleeding signs. Dose may be individualized and closer clinical monitoring applied by the care team.
Onset
delayed
Evidence
probable
Severity
Major

What happens

An increased risk of bleeding

Interaction Deep Dive

If sertraline is used together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients that their bleeding risk is elevated.1. Hemostasis depends in part on serotonin being released by platelets. Studies using case-control and cohort designs have demonstrated that taking SSRIs (for example, sertraline) alongside anticoagulants carries an association with a greater bleeding risk 231. Using sertraline at the same time as an anticoagulant may increase the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.

Why it happens (mechanism)

Release of serotonin by platelets; additive effects on hemostasis

How to manage this interaction

The good news: your care team can manage this. If both medicines are prescribed for you, keep taking them as directed unless your prescriber tells you otherwise.

  • Your team may monitor you more closely for bleeding, and your doses may be adjusted and individualized as needed.
  • Watch for and report nosebleeds, easy bruising, tiny red skin spots, unusual or heavy bleeding, blood in urine or stool, or black stools.
  • Seek urgent care for bleeding that won't stop or signs of serious bleeding.
  • Tell every pharmacist and prescriber that you take both, and check before adding aspirin, NSAIDs, or other blood thinners.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

4 reports — tap to read

a) A retrospective cohort study (n=234) found a heightened risk of clinically relevant bleeding (hospital admission for bleeding) among patients taking warfarin for atrial fibrillation while also on SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus an SSRI (n=117) were matched with randomly chosen patients who received warfarin alone (n=117). The SSRIs included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes across 213.9 treatment years, whereas in the warfarin-only group, 10 patients had 14 bleedings across 586.4 treatment years. The corresponding overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. The hazard ratio for initial bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) relative to warfarin alone. In patients who bled during concurrent administration, the SSRI involved was sertraline or citalopram. Introducing an SSRI was not linked to any change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The findings may be constrained by prior bleeding events, uncertain patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids and anticoagulants other than warfarin from the model 2.

b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking concurrent selective serotonin reuptake inhibitors (SSRIs) found an elevated risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also on a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients on SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.

c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, the influence of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the trial, all participants took warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or the placebo group; the sertraline dose was progressively raised from 50 mg/day to 200 mg/day. Prothrombin time was checked before each warfarin dose and at intervals afterward. The investigators concluded that sertraline did not increase warfarin's anticoagulant effects to a clinically significant extent, even though sertraline was administered at a higher-than-usual dose 4.

d) Case reports and epidemiological studies (case-control and cohort studies) have shown a link between the use of drugs that impair serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.

Common questions

Can I take Sulodexide and Sertraline together?

Combining sertraline and sulodexide can add up to a higher bleeding risk, so watch for bruising or bleeding and keep your care team in the loop. Don't stop either drug on your own; let them monitor you and adjust as needed. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sulodexide and Sertraline interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How is the Sulodexide and Sertraline interaction managed?

The good news: your care team can manage this. If both medicines are prescribed for you, keep taking them as directed unless your prescriber tells you otherwise. Your team may monitor you more closely for bleeding, and your doses may be adjusted and individualized as needed. Watch for and report nosebleeds, easy bruising, tiny red skin spots, unusual or heavy bleeding, blood in urine or stool, or… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Sulodexide or Sertraline need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (4)

  1. Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
  2. Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
  3. Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
  4. Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.